Abstract
Hepatic fat accumulation is an event often seen in obese patients and can cause metabolic disorders such as inflammation, mitochondrial disfunction, insulin resistance, leading to hepatic steatosis and cirrhosis. Pre-clinic studies shows that oral treatment with NAD+ precursors can stimulate mtUPR (mitochondrial unfolded protein response) mechanism, recovering mitochondrial and hepatic fu…